Project Number ADDF-34 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator Ducharme, Simon Principal Investigator Ducharme, Simon Awardee Organization MCGILL UNIVERSITY Awardee State Québec Contact PI Country Canada Project Detail Funding Opportunity Announcement ADDF-Clinical Trial Program FY Overall Cost $1,399,078 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management